Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials

被引：57
|
作者：
Askew, Deborah A. [1 ]
Mickan, Sharon M.
Soyer, Peter
Wilkinson, David
机构：
[1] Univ Queensland, Sch Med, Discipline Gen Practice, Herston, Qld 4006, Australia
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2009年 / 48卷 / 05期
关键词：
0.5-PERCENT FLUOROURACIL CREAM; TOPICAL; 5-FLUOROURACIL; SOLAR KERATOSIS; FOLLOW-UP; IMIQUIMOD; METAANALYSIS; EFFICACY; CRYOSURGERY; GUIDELINES; MANAGEMENT;
D O I：
10.1111/j.1365-4632.2009.04045.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：453 / 463
页数：11
相关论文
共 50 条
  • [31] Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness
    Emmerich, Veronica K.
    Cull, Deborah
    Kelly, Katherine A.
    Feldman, Steven R.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2075 - 2078
  • [32] Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
    Eggert Stockfleth
    Nathalie Bégeault
    Alain Delarue
    Dermatology and Therapy, 2022, 12 : 467 - 479
  • [33] Effect of a Pre-Treatment Educational Video in Improving Patient Satisfaction with 5-Fluorouracil Treatment for Actinic Keratoses: A Randomized Controlled Trial
    Agbai, Oma N.
    Davari, Parastoo
    Johnson, Jennifer
    Armstrong, April
    Fazel, Nasim
    DERMATOLOGY AND THERAPY, 2016, 6 (04) : 675 - 681
  • [34] Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial
    Stockfleth, Eggert
    Jouary, Thomas
    Farnetani, Francesca
    Pascual, Antonio Macaya
    Agudo, Cecilia De Almeida
    Voisard, Jean-Jacques
    Begeault, Nathalie
    Delarue, Alain
    DERMATOLOGY AND THERAPY, 2023, 13 (04) : 1013 - 1027
  • [35] Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study
    Neugebauer, Romain
    Su, Katherine A.
    Zhu, Zheng
    Sokil, Monica
    Chren, Mary-Margaret
    Friedman, Gary D.
    Asgari, Maryam M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) : 998 - 1005
  • [36] A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate
    Serra-Guillen, C.
    Nagore, E.
    Hueso, L.
    Llombart, B.
    Requena, C.
    Sanmartin, O.
    Botella-Estrada, R.
    Guillen, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (02) : 429 - 433
  • [37] Adherence to a Topical Regimen of 5-Fluorouracil, 0.5%, Cream for the Treatment of Actinic Keratoses
    Yentzer, Brad
    Hick, Jeff
    Williams, Lisa
    Inabinet, Robin
    Wilson, Rebekah
    Camacho, Fabian T.
    Russell, Gregory B.
    Feldman, Steven R.
    ARCHIVES OF DERMATOLOGY, 2009, 145 (02) : 203 - 205
  • [38] Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial
    Rahangdale, Lisa
    Lippmann, Quinn K.
    Garcia, Katelyn
    Budwit, Debra
    Smith, Jennifer S.
    van Le, Linda
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (04) : 314.e1 - 314.e8
  • [39] Effect of a Pre-Treatment Educational Video in Improving Patient Satisfaction with 5-Fluorouracil Treatment for Actinic Keratoses: A Randomized Controlled Trial
    Oma N. Agbai
    Parastoo Davari
    Jennifer Johnson
    April Armstrong
    Nasim Fazel
    Dermatology and Therapy, 2016, 6 : 675 - 681
  • [40] Pre-treatment with topical 5-fluorouracil increases the efficacy of daylight photodynamic therapy for actinic keratoses - A randomized controlled trial
    Wiegell, Stine Regin
    Fredman, Gabriella
    Andersen, Flemming
    Bjerring, Peter
    Paasch, Uwe
    Haedersdal, Merete
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 46
12345